Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane D Miller

Showing results (71-80 of 246) with videos related to

Pageof 25
Sort By:
Molecular Endocrinology (Baltimore, Md.)|September 20, 2008
Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathwaysRamesh Narayanan, Christopher C Coss, Muralimohan Yepuru, et al.
Journal of Medicinal Chemistry|July 13, 2012
Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agentsJianjun Chen, Sunjoo Ahn, Jin Wang, et al.
Biochimica Et Biophysica Acta|May 29, 2007
Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alphaFeng Hao, Mingqi Tan, Xuemin Xu, et al.
Current Drug Metabolism|August 13, 2015
Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1P S S Rao, Narasimha M Midde, Duane D Miller, et al.
Pharmaceutical Research|May 3, 2014
LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancerDi Wen, Deepak Chitkara, Hao Wu, et al.
Journal of Medicinal Chemistry|April 4, 2013
Discovery of 4-Aryl-2-benzoyl-imidazoles as tubulin polymerization inhibitor with potent antiproliferative propertiesMin Xiao, Sunjoo Ahn, Jin Wang, et al.
Pharmaceutical Research|September 4, 2009
Effects of selective androgen receptor modulator (SARM) treatment in osteopenic female ratsJeffrey D Kearbey, Wenqing Gao, Scott J Fisher, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2019
Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate CancerRuinan Yang, Hao Chen, Dawei Guo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 15, 2011
Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in miceSunjoo Ahn, Jeffrey D Kearbey, Chien-Ming Li, et al.
International Journal of Molecular Sciences|March 6, 2021
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate CancerMichael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, et al.
Pageof 25

Showing results (71-80 of 246) with videos related to

Sort By:
Pageof 25
Molecular Endocrinology (Baltimore, Md.)|September 20, 2008
Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathwaysRamesh Narayanan, Christopher C Coss, Muralimohan Yepuru, et al.
Journal of Medicinal Chemistry|July 13, 2012
Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agentsJianjun Chen, Sunjoo Ahn, Jin Wang, et al.
Biochimica Et Biophysica Acta|May 29, 2007
Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alphaFeng Hao, Mingqi Tan, Xuemin Xu, et al.
Current Drug Metabolism|August 13, 2015
Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1P S S Rao, Narasimha M Midde, Duane D Miller, et al.
Pharmaceutical Research|May 3, 2014
LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancerDi Wen, Deepak Chitkara, Hao Wu, et al.
Journal of Medicinal Chemistry|April 4, 2013
Discovery of 4-Aryl-2-benzoyl-imidazoles as tubulin polymerization inhibitor with potent antiproliferative propertiesMin Xiao, Sunjoo Ahn, Jin Wang, et al.
Pharmaceutical Research|September 4, 2009
Effects of selective androgen receptor modulator (SARM) treatment in osteopenic female ratsJeffrey D Kearbey, Wenqing Gao, Scott J Fisher, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2019
Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate CancerRuinan Yang, Hao Chen, Dawei Guo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 15, 2011
Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in miceSunjoo Ahn, Jeffrey D Kearbey, Chien-Ming Li, et al.
International Journal of Molecular Sciences|March 6, 2021
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate CancerMichael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, et al.
Pageof 25